Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 63 Cisplatin 40 Pemetrexed 38 Drug Therapy 37 osimertinib 22 anlotinib 22 Etoposide 20 tislelizumab 17 Radiotherapy 17 Paclitaxel 17 Surgical Procedures, Operative 16 pembrolizumab 15 toripalimab 14 130-nm albumin-bound paclitaxel 14 aflutinib 13 Docetaxel 13 Bevacizumab 12 sintilimab 10 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Injections 9 durvalumab 8 cemiplimab 8 Radiosurgery 8 Platinum 8 PM 01183 8 Immunotherapy 8 atezolizumab 7 Platinum Compounds 7 Blood Specimen Collection 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × rezivertinib × Thoracic × Clear all

NCT06955325 2025-05-06

UPLIFT

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡